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The transport and reduction of dimesna (Na-2-mercaptoethane sulfonate disulfide) was studied in vitro 
using isolated, perfused rat kidney, and isolated renal epithelial cells. Cellular uptake of dimesna was 
found to be dependent on an active transport mechanism working across the luminal brush border, with 
an app. Km of -22 pM and V,,,,, -1.4 nmol. lo6 cells-’ .min -‘. Among other low molecular thiols or 
disulfides reduced glutathione was the only one to exert competitive inhibition. y-GT-activity or cellular 
GSH status had no influence on renal uptake of dimesna, but the intracellular reduction rate was 
dependent on access to reduced glutathione as a cofactor. 
Kidney Mercaptoethane sulfonate Glutathione Transport 
1. INTRODUCTION 
During recent years, Na-mercaptoethane sul- 
fonate (HS-CH2-CH2-S03)-Na+ (Mesna) has 
proven to be a valuable drug in the protection 
against urothelial toxicity in patients treated with 
oxazaphosphorine cytostatics (ex. cyclophospha- 
mide) [1,2]. A series of clinical and experimental 
studies have been performed, and it is now well 
established that Mesna after oral or parenteral 
administration is circulating in its chemically inert 
disulfide form (Dimesna) and does not penetrate 
into living tissues, except the kidney [3,4]. Here, 
however, it is extracted from the renal vasculature 
and undergoes an intracellular reduction mechan- 
ism whereby the disulfide bond is split and the 
reactive thiol form (Mesna) is excreted to the 
tubular lumen where it is available for binding and 
detoxifying acrolein and other irritating meta- 
bolites of oxazaphosphorine cytostatics. The bio- 
chemical reaction-pathway for Dimesna reduction 
has been studied in vitro and seems to involve the 
two cytosolic enzymes thiol transferase and gluta- 
thione reductase with reduced glutathione (GSH) 
and reduced pyridine nucleotide (NADPH) as co- 
factors [4]. 
Among the various cellular functions ascribed to 
GSH, an involvement with membrane integrity and 
transport processes has been suggested [5,6]. Thus, 
the glutathione status of the kidney may be of 
relevance to the pharmacodynamics of Dimesna. 
The group of patients who will potentially receive 
this drug are likely to be in a poor nutritional state, 
which may upset their whole-body glutathione 
status [7]. This study therefore aims to investigate 
the relationship between GSH status and the 
transport and reduction of Dimesna in the kidney, 
as well as to study the polarity and specificity of 
Dimesna uptake into renal epithelial cells. 
2. MATERIALS AND METHODS 
Male Sprague-Dawley rats (180-230 g) were 
kept in stainless teel cages with free access to tap 
water and pelleted rat food. Kidney perfusion was 
performed as in [8]. To obtain a non-filtering 
kidney the perfusate concentration of albumin was 
increased to lo%, thereby creating an osmotic 
pressure of 55 mm Hg, and the perfusion pressure 
simultaneously decreased to 50 cm Hz0 [9]. Isola- 
tion of renal tubular epithelial cells was performed 
as in [lo]. The cytosolic fraction from a kidney 
Published by Elsevier Biomedical Press 
00145793/82/0000-0000/$2.75 0 Federation of European Biochemical Societies 354 
Volume 150, number 2 FEBS LETTERS December 1982 
cortex homogenate was recovered as the 105 000 x 
g supernatant . 
Double-distilled water was used for all solutions. 
Mesna, [3H]Mesna, Dimesna and [14C]Dimesna 
were kindly supplied by Asta-Werke AG, Degussa 
Pharma Gruppe (Bielefeld). Anthglutin was a 
generous gift from Dr M. Tanaka, Sankyo 
Laboratories (Tokyo). All other reagents were of 
at least reagent grade and were purchased from 
local sources. 
Mesna was analyzed as total thiol as in [l l] or as 
in [12] as modified in [13]; in cellular systems after 
subfraction of glutathione as measured by high- 
performance liquid chromatography [14]. Dimesna 
was assayed as reducible disulfides after treatment 
with sodium borohydride as in [ 131. 
Cellular uptake of radiolabelled Mesna and 
Dimesna was determined by incubation of isolated 
kidney cells with the labelled compound, separa- 
tion of the cells from the medium by rapid cen- 
trifugation in a Microfuge, washing once with 
fresh medium and lysis of the cells with distilled 
water, whereupon cellular radioactivity was 
counted in a Beckman LS 100 liquid scintillation 
counter. 
Metabolic incubations were routinely performed 
in rotating round-bottom glass flasks at 37°C 
under continuous gassing with carbogen (95% 
02,5% COZ), or 100% Nz. Incubation medium was 
a modified Krebs-Henseleit bicarbonate buffer 
(pH 7.4) supplemented with 25 mM HEPES (4- 
(2-hydroxyethyl)-1-piperazineethanesulfonic acid). 
3. RESULTS AND DISCUSSION 
Previous investigations [15] have demonstrated 
that after oral as well as parenteral administration, 
Mesna undergoes rapid oxidation in plasma and 
circulates as the chemically inert disulfide 
(Dimesna). Thus, the various cells and tissues in 
the body are exposed to Dimesna only, and since 
most cells do not take up low-molecular disulfides 
(cf. [4]) Dimesna remains in the extracellular 
space. In the kidney, however, Dimesna is taken up 
and undergoes a reductive activation which is a 
prerequisite for its local uroprotective effect. This 
work is an extension of earlier investigations on 
whole-body handling and metabolism of 
Mesna/Dimesna and focusses on the renal 
transport and metabolism functions. 
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Fig. 1. Uptake of [r4C]Dimesna into isolated rat kidney 
cells. (A) Cells incubated with 1OOpM radiolabelled 
Dimesna under continuous carbogen gassing at various 
temperatures: (0-O) 4°C; (ti) 20°C; (E-U) 
29°C; (H) 37°C. (B) Cells incubated with 1 mM 
radio-labelled Dimesna under continuous carbogen 
gassing at 37°C: (p--v) control; (M) plus 
Anthglutin 1 mM; (v---v) cells preincubated with 
10 pM FCCP for 10 min prior to addition of Dimesna. 
Being a salt of a weak acid, Dimesna is highly 
water-soluble and transmembranal uptake must be 
expected to require an active, energy-requiring 
transport mechanism. The existence of such a 
function is supported by the effect of incubation 
temperature on uptake rate which is illustrated in 
fig. 1A. Further support for this hypothesis is 
derived from the dramatic effect on Dimesna up- 
take observed upon treatment of the cells with 
10 PM carbonyl cyanide p-trifluoromethoxy- 
phenylhydrazide (FCCP) (fig. 1B) which lowers 
cellular ATP level to 20% of control value 1161. 
A great variety of active transport mechanisms 
for various compounds are operating across the 
renal tubular epithelium, one of which is suggested 
to be coupled to the activity of the brush border 
glycoprotein enzyme y-glutamyltransferase (y- 
GT), which is prominent in kidney and intestines 
[6]. To investigate whether y-GT is involved in 
Dimesna uptake in renal cells, the potent y-GT in- 
hibitor Anthglutin [17) was added to the incubate. 
As is seen from fig. lB, no effect on Dimesna up- 
take was observed despite a 90% inhibition of y- 
GT activity, which refutes a quantitatively impor- 
tant coupling. 
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Fig. 2. Kinetics of Dimesna uptake in isolated rat kidney 
cells. Incubations were performed at 37°C under 
continuous carbogen gassing as described in section 2. 
The cell concentration in the incubate was 1 x 106/ml 
and the initial incubation vol. was 5 ml. 
In fig. 1B the perfusate concentration of 
Dimesna is lo-times that in fig. lA, but the rates of 
cellular uptake are almost identical. This led us to 
study the kinetics of Dimesna uptake in isolated 
kidney cells, and the results are shown in fig. 2. 
From the data plotted in this figure - which are 
calculated from the first 5 min of incubation when 
the uptake rate is still linear - an apparent K,,, for 
the Dimesna transport mechanism is computed to 
-22 PM and the I’,,,,, to -1.4 nmol. lo6 
cells- ’ . min- ‘. These values are within the range of 
transport capacity for other compounds taken up 
in isolated kidney cells [ 171. 
The influence of other low molecular thiols and 
disulfides on Dimesna uptake was studied at con- 
centration ratios ranging from 1 : 1 to 1: 100 
(table 1). Only in the case of reduced glutathione at 
high excess was an inhibitory effect observed, sug- 
gesting that the transport mechanism for Dimesna 
is quite selective. Whether the inhibitory effect of 
GSH was due to competition for binding sites, or 
to other mechanisms is still an open question - at 
least in the liver it is shown that extracellular GSH 
augments the uptake of methotrexate, probably by 
Table 1 
Influence of various low-molecular thiols and 
disulfides on Dimesna uptake into isolated rat kidney 
cells (pmol MSSM. lo6 cells-‘. min-‘) 
Additions to incubate Uptake rate 
None 105 + 30 
GSSG, 10pM 116 + 42 
GSSG, 1000 PM 100 + 21 
Cystine, 10 PM 98 & 19 
Cystine, 500 PM 92 + 15 
GSH, 10pM 98 + 26 
GSH, 1OOO~M 70 & 12 
Cysteine, 10 pM 113 * 30 
Cysteine, 1000 pM 104 + 19 
N-acetylcysteine, 10 pM 99 + 12 
N-acetylcysteine, 1000 /IM 104 + 23 
Mesna, 10 pM 112 + 15 
Mesna, 1000 PM 94+ 8 
The concentration of [14C]Dimesna was 10pM in all 
incubations. Experiments performed at 37°C under 
carbogen atmosphere. Results given as means + SD of 
3 separate expts 
Table 2 
Influence of renal cellular GSH content on rates of 
uptake and reduction of Dimesna 
Cellular GSH Rate of Dimesna Rate of thiol 
content uptake formation 
(nmol/ lo6 cells) (nmol. lo6 (nmol. lo6 
cells- ’ . min-i) cells- ’ . mini) 
29 + 4 0.82 + 0.12 1.24 + 0.38 
18 + 4 0.86 + 0.19 0.62 + 0.18 
8+2 0.78 + 0.08 0.19 +- 0.04 
Incubations were performed at 37°C under Nz 
atmosphere. Initial Dimesna concentration was 100 PM. 
Cell concentration was 2 X lo6 cells/ml 
interfering with the balance of SH- and S-S- 
groups in the plasma membrane, and it is suggested 
that this redox state may be involved in the control 
of membrane permeability [5]. However, in vivo 
the effect of GSH on Dimesna uptake is likely to 
be marginal since both plasma and urinary GSH 
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concentrations are in the micromolar range [18]. 
The reaction sequence previously proposed for 
intracellular reduction of Dimesna involves 
cytosolic GSH as a co-factor [4]. Consequently, 
cells deficient in GSH would be expected to have a 
lower Dimesna-reducing capacity, which is con- 
firmed by the data presented in table 2. Partial 
GSH depletion achieved by preperfusing the 
kidneys with 4 PM diethylmaleate for 2 min 
diminishes cellular GSH content by -3O%, and 
after 5 min preperfusion the content is -25-30% 
of the normal [19]. These cells retain unchanged 
viability for at least 2 h and neither the capacity to 
take up amino acids [19] nor Dimesna (table 2) 
seems to be impaired. Dimesna reduction rate, 
however, is dramatically decreased along with the 
cellular GSH concentration, reflecting the limited 
supply of a necessary co-factor in the reaction se- 
quence [4] : 
(i) MSSM + GSH -+ MSH + GS-SM 
(ii) GS-SM + GSH -+ MSH + GSSG 
(iii) GSSG + NADPH + H+ + 2 GSH + NADP+ 
The rate of Dimesna reduction could be restored 
completely by incubating the partly GSH-depleted 
cells with an amino acid mixture containing 
glutamate, glycine and cyst(e)ine, thereby 
replenishing the GSH pool. 
Thus, adequate levels of renal cellular GSH is a 
prerequisite for the uroprotective action of 
Dimesna. Normally, the biological halflife of GSH 
is short in the kidney, -30 min [20], and resyn- 
thesis is dependent on a supply of precursor amino 
acids, whereof the intracellular level of cysteine 
[19] appears to be the limiting factor, and in the 
clinical situation the importance of an adequate 
dietary intake of sulphur-containing amino acids 
must be remembered. Work in [4] indicated that 
the all-over renal handling of Dimesna consists of 
glomerular filtration, tubular reabsorption, in- 
tracellular reduction and subsequent secretion of 
Mesna to the tubular lumen, and of any Dimesna 
exceeding the reductive capacity to the peritubular 
capillaries. Prompted by the observed influence of 
extracellular GSH on Dimesna uptake and the fact 
that plasma GSH is actively extracted in the kidney 
[8,21,22] experiments were undertaken to establish 
whether Dimesna could also be absorbed from the 
basolateral side of the tubular epithelium. Filtering 
and non-filtering kidneys were perfused for 20 min 
with [14C]Dimesna-containing medium, then with 
a Dimesna-free perfusate for 10 min, and the 
radioactivity retained in the tissue was compared. 
In the non-filtering kidney, only traces of radioac- 
tivity were found, whereas the filtering kidney ex- 
hibited about lOO-fold higher counts/weight unit. 
Thus, it seems that the main route for Dimesna up- 
take in the kidney is across the luminal brush 
border and that glomerular filtration rate may be 
a limiting factor in the activation of Dimesna as a 
local protector against oxaphosphorine toxicity. 
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